Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Tenn

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 22, 2017
Advances in rhinitis: Models and mechanismsAnne K Ellis, Mark W Tenn
Current Opinion in Allergy and Clinical Immunology|September 11, 2018
Nasal challenges in allergen immunotherapy trialsMark W Tenn, Matthew Rawls, Anne K Ellis
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 27, 2018
Onset of action for loratadine tablets for the symptomatic control of seasonal allergic rhinitis in adults challenged with ragweed pollen in the Environmental Exposure Unit: a post hoc analysis of total symptom scoreMark W Tenn, Lisa M Steacy, Charlene C Ng, et al.
The Journal of Allergy and Clinical Immunology|October 1, 2019
Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen seasonsAnne K Ellis, Charles W Frankish, Kristen Armstrong, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 13, 2018
Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unitAnne K Ellis, Mark W Tenn, Lisa M Steacy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 18, 2019
Clinical standardization of two controlled allergen challenge facilities: The Environmental Exposure Unit and the Biogenics Research ChamberAnne K Ellis, Robert L Jacobs, Mark W Tenn, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 22, 2017
Advances in rhinitis: Models and mechanismsAnne K Ellis, Mark W Tenn
Current Opinion in Allergy and Clinical Immunology|September 11, 2018
Nasal challenges in allergen immunotherapy trialsMark W Tenn, Matthew Rawls, Anne K Ellis
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 27, 2018
Onset of action for loratadine tablets for the symptomatic control of seasonal allergic rhinitis in adults challenged with ragweed pollen in the Environmental Exposure Unit: a post hoc analysis of total symptom scoreMark W Tenn, Lisa M Steacy, Charlene C Ng, et al.
The Journal of Allergy and Clinical Immunology|October 1, 2019
Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen seasonsAnne K Ellis, Charles W Frankish, Kristen Armstrong, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 13, 2018
Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unitAnne K Ellis, Mark W Tenn, Lisa M Steacy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 18, 2019
Clinical standardization of two controlled allergen challenge facilities: The Environmental Exposure Unit and the Biogenics Research ChamberAnne K Ellis, Robert L Jacobs, Mark W Tenn, et al.
Pageof 1